Medical Products Laboratories, Inc. FDA Inspection Record
Medical Products Laboratories, Inc. is an FDA-registered facility (FEI 2513595) located in Philadelphia, PA, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK. RegDataLab tracks 8 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Jul 13, 2023: Voluntary Action Indicated (VAI)
- Inspections on record
- 8 (7 VAI, 1 NAI)
- Last OAI inspection
- None on record
- Warning letters
- 1 listed by FDA for this FEI, latest Apr 9, 2026
- Recalls as the recalling firm
- 2, latest Nov 12, 2025
- Import refusals
- 10 or more
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Jul 13, 2023 | Voluntary Action Indicated (VAI) | Equipment Design, Size and Location (21 CFR 211.63) |
| Mar 13, 2020 | Voluntary Action Indicated (VAI) | No citations listed |
| Oct 12, 2017 | Voluntary Action Indicated (VAI) | No citations listed |
| Jul 21, 2015 | Voluntary Action Indicated (VAI) | SOPs not followed / documented (21 CFR 211.100(b)) Quarantine of Rejected Components et. al. (21 CFR 211.89) Scientifically sound laboratory controls (21 CFR 211.160(b)) |
| Feb 24, 2014 | Voluntary Action Indicated (VAI) | Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Calibration/Inspection/Checking not done (21 CFR 211.68(a)) Absence of Written Procedures (21 CFR 211.100(a)) Procedures for non-sterile drug products (21 CFR 211.113(a)) and 10 more |
| Jul 13, 2011 | No Action Indicated (NAI) | No citations listed |
| Apr 27, 2011 | Voluntary Action Indicated (VAI) | Buildings not maintained in good state of repair (21 CFR 211.58) |
| Jun 14, 2010 | Voluntary Action Indicated (VAI) | Equipment Design, Size and Location (21 CFR 211.63) Absence of Written Procedures (21 CFR 211.100(a)) Procedures for non-sterile drug products (21 CFR 211.113(a)) Adequate number of batches on stability (21 CFR 211.166(b)) and 10 more |
Warning letters
- Apr 9, 2026: CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug. Read the letter on FDA.gov.
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Nov 12, 2025 | Class II | D-0179-2026 | Walgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN… Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis |
| Jun 23, 2010 | Class II | D-019-2011 | NaFrinse, Fluoride Mouthrinse in 10 ml cups. The product is shipped 12 x 10 ml x 24. CGMP Deviations: Firm did not follow SOP/GMPs during manufacturing. |
FDA record score
41 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
10 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Warning letter, no close-out letter listed | Apr 9, 2026 | 30 x 1 | 30 |
| Class II recall D-0179-2026, this FEI as the recalling firm | Nov 12, 2025 | 4 x 1 | 4 |
| Inspection classified VAI | Jul 13, 2023 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Mar 13, 2020 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Oct 12, 2017 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Jul 21, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Feb 24, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Apr 27, 2011 | 10 years or older, so it adds no points | 0 |
| Class II recall D-019-2011, this FEI as the recalling firm | Jun 23, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jun 14, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Medical Products Laboratories, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Medical Products Laboratories, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Medical Products Laboratories, Inc.
- Location
- Philadelphia, PA (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK
- Source
- both